J. Goldman & CO LP Acadia Pharmaceuticals Inc Put Options Transaction History

J. Goldman & CO LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $240,300 - $346,275	-13,500 Reduced 33.33%	27,000 $646,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $660,960 - $847,260	40,500 New	40,500 $762,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $156,120 - $326,640	12,000 Added 80.0%	27,000 $381,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $314,100 - $412,500	15,000 New	15,000 $363,000
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $846,950 - $1.42 Million	-65,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $979,550 - $1.45 Million	65,000 New	65,000 $993,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.